Pioglitazone-induced increase of insulin sensitivity in the muscles of the obese Zucker fa/fa rat cannot be explained by local adipocyte differentiation

Diabetologia

Volumn 41, Issue 8, 1998, Pages 963-968

  Hallakou, S ^a,b   Foufelle, F ^a   Doare L ^b   Kergoat, M ^b   Ferre P ^a  

^a INSERM   (France)

^b LIPHA Research Laboratory   (France)

Author keywords

Adipocyte differentiation; Glucose utilization; Muscle; PPAR ; Thiazolidinedione; Zucker fa fa rat

Indexed keywords

PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PIOGLITAZONE;

ADIPOCYTE; ANIMAL MODEL; CELL DIFFERENTIATION; CONFERENCE PAPER; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC OBESITY; DRUG MECHANISM; GENE EXPRESSION REGULATION; GLUCOSE UTILIZATION; INSULIN SENSITIVITY; NONHUMAN; PRIORITY JOURNAL; RAT;

ADIPOCYTES; ANIMALS; ANTIGENS, CD95; CELL DIFFERENTIATION; FEMALE; GENE EXPRESSION; GLUCOSE; GLUCOSE CLAMP TECHNIQUE; HYPOGLYCEMIC AGENTS; INSULIN; MUSCLE, SKELETAL; OBESITY; PHOSPHOENOLPYRUVATE CARBOXYKINASE (GTP); RATS; RATS, ZUCKER; RNA, MESSENGER; THIAZOLES; THIAZOLIDINEDIONES;

EID: 0031816269     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001250051014     Document Type: Conference Paper

References (33)

1. Suter SL, Nolan JJ, Wallace P, Gumbiner B, Olelsky J (1992) Metabolic effects of new oral hypoglycemic agent CS-045 in NIDDM subjects. Diabetes care 15: 193-203
2. Nolan JJ, Ludvik B, Beerden P, Joyce M, Olefsky J (1994) Improvement in glucose tolerance and insulin resistance in obese subjects treated with troglitazone. N Engl J Med 3: 1188-1193
3. Bowen L, Steven PP, Stevenson R, Shulman CI (1991) The effect of CP-68772, a thiazolidine derivative, on insulin sensitivity in lean and obese Zucker rats. Metabolism 40: 1025-1030
4. Lehmann JM, Moore LB, Smith-Oliver TA, Wilkinson WO, Willson TM, Kliewer SA (1995) An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor γ. J Biol Chem 270: 12953-12956
5. Tontonoz P, Hu E, Graves RA, Budavari AI, Spiegelman B (1994) mPPARγ2: tissue-specific regulator of an adipocyte enhancer. Genes Dev 8: 1224-1234
6. Chawla A, Schwarz EJ, Dimaculangan DD, Lazar MA (1994) Peroxisome proliferator-activated receptor (PPAR)γ: adipose-predominant expression and induction early in adipocyte differentiation. Endocrinology 135: 798-800
7. Sandouk T, Reda D, Hofmann C (1993) Antidiabetic agent pioglitazone enhances adipocyte differentiation of 3T3-F442A cells. Am J Physiol 264:CT1600-C1608
8. Tontonoz P, Hu E, Devine J, Beale EG, Spiegelman B (1995) PPARγ2 regulates adipose expression of the phosphoenolpyruvate carboxykinase gene. Mol Cell Biol 15: 351-357
9. Tontonoz P, Hu E, Spiegelman B (1994) Stimulation of adipogenesis in fibroblasts by PPARg2, a lipid-activated transcription factor. Cell 79: 1147-1156
10. Hu E, Tontonoz P, Spiegelman B (1995) Transdifferentiation of myoblasts by the adipogenic transcription factors PPARγ and C/EBPα Proc Natl Acad Sci (USA) 92: 9856-9860
11. Teboul M, Gaillard D, Staccini L, Inadera H, Amri E-Z, Grimaldi P (1995) Thiazolidinediones and fatty acids convert myogenic cells into adipose-like cells. J Biol Chem 270: 28183-28187
12. Hallakou S, Doaré L, Foufelle F, Kergoat M, Guerre-Millo M, Berthault M-F et al. (1997) Pioglitazone induces in vivo adipocyte differentiation in the obese Zucker fa/fa rat. Diabetes 46: 1393-1399
13. Burnol A-F, Leturque A, Ferré P, Girard J (1983) A method for quantifying insulin sensitivity in vivo in the anesthetized rat: the euglycemic insulin clamp technique coupled with isotopic measurement of glucose turnover. Reprod Nutr Dev 23: 429-435
14. Ferré P, Leturque A, Burnol A-F, Pénicaud L, Girard J (1985) A method to quantify glucose utilization in vivo in skeletal muscle and white adipose tissue of the anesthetized rat. Biochem J 228: 103-110
15. Goldberg AL, Martel SB, Kushmerick MJ (1975) In vitro preparations of the diaphragm and other skeletal muscles. Methods Enzymol 39: 82-94
16. Ariano MA, Armsrtrong RB, Edgerton VR (1973) Hindlimb muscle fiber populations of five mammals. J Histochem Cytochem 21: 51-55
17. Nesher H, Karl IE, Kaiser KE, Kipnis DM (1980) Epitrochlearis muscle.I. Mechanical performance energetics on fiber composition. Am J Physiol 239:E454-E460
18. Chomczynski P, Sacchi N (1987) Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156-159
19. Calkhoven CF, ABG (1996) Multiple steps in the regulation of transcription-factor level and activity. Biochem J 317: 329-342
20. Kraegen EW, James DE, Jenkins AB, Chisholm DJ (1985) Dose-response curves for in vivo insulin sensitivity in individual tissues in rats. Am J Physiol 248:E353-E362
21. Kraegen EW, James DE, Jenkins AB, Chisholm DJ, Storlien LH (1989) A potent in vivo effect of ciglitazone on muscle insulin resistance induced by high fat feeding of rats. Metabolism 38: 1089-1093
22. Vidal-Puig A, Jimenez-Linan M, Lowell BB, Hamann A, Hu E, Spiegelman B et al. (1996) Regulation of PPARγ gene expression by nutrition and obesity in rodents. J Clin Invest 97: 2553-2561
23. Fajas I, Auboeuf D, Raspé E, Schoonjans K, Lefebvre A-M, Saladin R et al. (1997) The organization, promoter analysis, and expression of the human PPARγ gene. J Biol Chem 272: 18779-18789
24. Auboeuf D, Rieusset J, Fajas I, Valuer P, Frering V, Riou JP et al. (1997) Tissue distribution and quantification of the expression of mRNAs of peroxisome proliferator-activated receptors and liver X receptor-α in humans. Diabetes 46: 1319-1327
25. Buckingham M (1992) Making muscle in mammals. Trends Genet 8: 144-148
26. Hotamisligil G, Shargill NS, Spiegelman B (1993) Adipose expression of tumor necrosis factor-α: direct role in obesity-linked insulin resistance. Science 259: 87-91
27. Peraldi P, Spiegelman B (1997) TNF-α: lien moléculaire entre obésité et résistance à l'insuline; In: journées de diabélologie; Flammarion Médecine-sciences France, pp 149-159
28. Hofmann C, Lorenz K, Braithwaite SS, Colca JR, Palazuk BJ, Hotamisligil GS et al. (1994) Altered gene expression for tumor necrosis factor-α and its receptors during drug and dietary modulation of insulin resistance. Endocrinology 134: 264-270
29. Miles PDG, Romeo OM, Higo K, Cohen A, Rafaat K, Olefsky JM (1997) TNF-α-induced insulin resistance in vivo and its prevention by troglitazone. Diabetes 46: 1678-1683
30. Müller G, Ertl J, Gerl M, Preibisch G (1997) Leptin impairs metabolic actions of insulin in isolated rat adipocytes. J Biol Chem 272: 10585-10593
31. De Vos P, Lefebvre A-M, Miller SG, Guerre-Millo M, Wong K, Saladin R et al. (1996) Thiazolidinediones repress ob gene expression in rodents via activation of peroxisome proliferator-activated receptor γ. J Clin Invest 98: 1004-1009
32. Yokomizo T, Izumi T, Chang K, Takuma Y, Shimizu T (1997) A G-protein-coupled receptor for leukotriene B4 that mediates chemotaxis. Nature 387: 620-624
33. Burant CF, Sreenan S, Hirano K-I, Tai T-AC, Lohmiller J, Lukens J et al. (1997) Troglitazone action is independent of adipose tissue. J Clin Invest 100: 2900-2908